New additions further expand and enhance health
plan offerings to members with a comprehensive virtual experience
across key specialty care areas
Amwell® (NYSE: AMWL), a national telehealth leader, today
announced the expansion of its virtual specialty provider and
clinical program portfolio by adding Amwell Musculoskeletal (MSK)
and Dermatology programs. These new programs are designed to
address some of the most pervasive and costly areas of healthcare
and are part of Amwell efforts to enable health plans to better
care for members across a wide breadth of specialty care areas and
provide a holistic member experience. As with the entire Amwell
platform, health plans can brand and use any or all of these
programs as part of their own digital offerings.
“Our new and expanded clinical programs are models for
tech-enabled, longitudinal care delivery. They allow patients to
receive care from a known provider while offering personalized,
digital interactions to keep treatment on track, even for chronic
conditions. Offerings such as these enable health plans to drive
better member outcomes while avoiding unnecessary procedures or
costs,” said Dr. Ido Schoenberg, Chairman and CEO, Amwell. “These
programs thoughtfully expand our ecosystem of specialty care
services, allowing health plans to offer a comprehensive care
experience across a wide range of care needs, via a single partner
with a digital care delivery platform designed to treat the whole
person, including transactional and longitudinal care needs across
in person, virtual and automated settings.”
Affecting about 50% of adults in the U.S., 1 musculoskeletal
conditions are a leading driver of medical spend for insurers2 and
a top condition driving cost for employers3. The Amwell MSK program
is designed to help health plans mitigate the challenges associated
with access to physical therapy, subsequent disruptions in
productivity, and associated costs. Designed to address all major
musculoskeletal issues at any point in the care journey, the
clinically validated programs include a customized physical therapy
plan, virtual coaching visits, a digital sensor kit to enable
guided exercise sessions, engagement services and access to
behavioral health resources to achieve better program adherence and
clinical outcomes.
The Amwell Dermatology Program offers quick and easy access to
quality dermatology care with board-certified dermatologists who
can treat nearly 3,000 conditions of the skin, hair and nails,
helping to solve for the nationwide shortage of dermatologists
which has led to an average wait time of 35-days for in-person
visits4. The Amwell program provides a more convenient alternative
to traditional in-person dermatology care and faster turnaround
times, with most diagnoses returned in just 24 hours, allowing
members to identify and address issues early and potentially
mitigate future costs.
You can learn more about the Amwell MSK Program here, and the
Amwell Dermatology Program here.
About Amwell
Amwell is a leading telehealth platform in the United States and
globally, connecting and enabling providers, insurers, patients,
and innovators to deliver greater access to more affordable, higher
quality care. Amwell believes that digital care delivery will
transform healthcare. The Company offers a single, comprehensive
platform to support all telehealth needs from urgent to acute and
post-acute care, as well as chronic care management and healthy
living. With over a decade of experience, Amwell powers telehealth
solutions for over 2,000 hospitals and 55 health plan partners with
over 36,000 employers, covering over 80 million lives. For more
information, please visit https://business.amwell.com/.
American Well, Amwell, Converge, Conversa, SilverCloud and
Carepoint are registered trademarks or trademarks of American Well
Corporation in the United States and other countries. All other
trademarks used herein are the property of their respective
owners.
Forward-Looking Statements
This press release contains forward-looking statements about us
and our industry that involve substantial risks and uncertainties
and are based on our beliefs and assumptions and on information
currently available to us. All statements other than statements of
historical facts contained in this press release, including
statements regarding our future results of operations, financial
condition, business strategy and plans and objectives of management
for future operations, are forward-looking statements. In some
cases, you can identify forward-looking statements because they
contain words such as “anticipate,” “believe,” “could,” “estimate,”
“expect,” “intend,” “may,” “plan,” “potential,” “predict,”
“project,” “should,” “will,” or “would,” or the negative of these
words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results,
performance, or achievements to be materially different from any
future results, performance or achievements expressed or implied by
the forward-looking statements. Forward-looking statements
represent our beliefs and assumptions only as of the date of this
release. These statements, and related risks, uncertainties,
factors and assumptions, include, but are not limited to: weak
growth and increased volatility in the telehealth market; inability
to adapt to rapid technological changes; increased competition from
existing and potential new participants in the healthcare industry;
changes in healthcare laws, regulations or trends and our ability
to operate in the heavily regulated healthcare industry; our
ability to comply with federal and state privacy regulations; the
significant liability that could result from a cybersecurity
breach; and other factors described under ‘Risk Factors’ in our
Form 10-K filed with the SEC on March 26, 2021. These risks are not
exhaustive. Except as required by law, we assume no obligation to
update these forward-looking statements, or to update the reasons
actual results could differ materially from those anticipated in
the forward-looking statements, even if new information becomes
available in the future. Further information on factors that could
cause actual results to differ materially from the results
anticipated by our forward-looking statements is included in the
reports we have filed or will file with the Securities and Exchange
Commission. These filings, when available, are available on the
investor relations section of our website at investors.amwell.com
and on the SEC’s website at www.sec.gov.
1
https://www.sciencedaily.com/releases/2016/03/160301114116.htm#:~:text=FULL%20STORY-,An%20estimated%20126.6%20million%20Americans%20(one%20in%20two%20adults)%20are,report%20issued%20today%20by%20the
2 Dieleman JL, Cao J, Chapin A, et al. US Health Care Spending by
Payer and Health Condition, 1996-2016. JAMA. 2020 3
https://www.businessgrouphealth.org/who-we-are/newsroom/press-releases/large-employers-double-down-on-efforts-to-stem-rising-us
4 https://www.jaad.org/article/S0190-9622(19)33319-5/fulltext
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220419005966/en/
Lindsay Sharifipour Lindsay.sharifipour@amwell.com
American Well (NYSE:AMWL)
Gráfico Histórico do Ativo
De Mai 2023 até Jun 2023
American Well (NYSE:AMWL)
Gráfico Histórico do Ativo
De Jun 2022 até Jun 2023
